MMP9 levels are also upregulated in the plasma in both mild cognitive impairment and Alzheimer’s disease patients (Bruno et al., 2009; Lorenzl et al., 2008; Tsiknia et al., 2022). This evidence concerns the gene MMP9 and Cognitive impairment.